Cargando…
CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts
BACKGROUND: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and locally aggressive disease. DMPM prognosis is dismal, mainly due to the lack of effective treatment options and the development of new therapeutic strategies is urgently needed. In this context, novel immunotherapy approaches...
Autores principales: | De Cesare, Michelandrea, Sfondrini, Lucia, Pennati, Marzia, De Marco, Cinzia, Motta, Valentina, Tagliabue, Elda, Deraco, Marcello, Balsari, Andrea, Zaffaroni, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727408/ https://www.ncbi.nlm.nih.gov/pubmed/26810896 http://dx.doi.org/10.1186/s12967-016-0781-4 |
Ejemplares similares
-
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
por: Sommariva, Michele, et al.
Publicado: (2013) -
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
por: El Bezawy, Rihan, et al.
Publicado: (2017) -
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
por: De Cesare, Michelandrea, et al.
Publicado: (2015) -
Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma
por: Zaffaroni, Nadia, et al.
Publicado: (2007) -
Exploiting poly(I:C) to induce cancer cell apoptosis
por: Bianchi, Francesca, et al.
Publicado: (2017)